November 5-6, 2025 | Boston Convention Center
Keynote: Executive Perspective: Digital Transformation
Nov 5th – 8:40 AM
This session explores how Amgen is harnessing emerging technologies to advance drug safety and discovery. Scott Skellenger and Aman Wasan will discuss strategies for data integrity, innovation culture, and balancing in-house development with vendor partnerships—offering insight into how Amgen is building a secure, agile, and technology-driven future across safety, regulatory, and clinical domains.
- Aman Wasan, CEO, ArisGlobal
- Scott Skellenger,VP – Digital, Technology, and Innovation – R&D Informatics & Global Infrastructure Services, Amgen
Keynote: The Road to AI Success: How to Operationalize for Sustainable Value
Nov 6th – 9:35-10:15 AM
The session will cover:
- Building the right foundation – data quality, governance, and infrastructure considerations
- Scaling to production – overcoming challenges in deployment and adoption
- Change management & culture – preparing teams for new ways of working
- Measuring Success – establishing KPIS to track value creation and sustainability
- Use Cases – how you’ve operationalized AI delivering sustainable valuePanelists:
- Lucinda Smith, Chief Safety Product Officer • Product Management,ArisGlobal
- Julie Thomas, Vice President, Global Medical Safety Operations,Johnson & Johnson
- Mariette Boerstoel, Senior Vice President, Worldwide Patient Safety Officer,Bristol Myers Squibb
- Ellen (Lena) Mishalov, Director, Pv Technological Innovations,Astellas Pharma
Find ArisGlobal at Booth #526
Visit our booth and learn more about LifeSphere, ArisGlobals’s cloud powered technology suite, and NavaX, the next generation cognitive computing engine to expedite R&D digitization for Life Sciences.
World Drug Safety Website and Agenda here
